SCHEMBL5149203

SCHEMBL5149203

c1ccc(N(c2ccccc2)c2ccccc2-c2ccccc2N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KCNA3 P22001 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CRHBP P24387 1/20 0.37
ATM Q13315 1/20 0.37
CRHR2 Q13324 1/20 0.37
TLR9 Q9NR96 1/20 0.37
NPSR1 Q6W5P4 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12853968 0.97 ALDH1A1 (0.42) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL29742677 0.97 ALDH1A1 (0.42) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL21364922 0.89 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL2784066 0.89 ALDH1A1 (0.38) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL28846480 0.89 ALDH1A1 (0.38) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL21364924 0.89 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL30021343 0.89 ALDH1A1 (0.38) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL21168448 0.89 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL21168443 0.89 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL733459 0.87 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12029106-B2 n-type semiconductor element, method for manufacturing n-type semiconductor element, wireless communication device, and merchandise tag TORAY INDUSTRIES, INC. (JP) 2024-07-02 US disclosed
US-12029107-B2 n-type semiconductor element, method for producing n-type semiconductor element, wireless communication device, and product tag TORAY INDUSTRIES, INC. (JP) 2024-07-02 US disclosed
US-20220185951-A1 n-TYPE SEMICONDUCTOR ELEMENT, METHOD FOR MANUFACTURING n-TYPE SEMICONDUCTOR ELEMENT, WIRELESS COMMUNICATION DEVICE, AND MERCHANDISE TAG TORAY INDUSTRIES, INC. (JP) 2022-06-16 US disclosed
US-20220158098-A1 n-TYPE SEMICONDUCTOR ELEMENT, METHOD FOR PRODUCING n-TYPE SEMICONDUCTOR ELEMENT, WIRELESS COMMUNICATION DEVICE, AND PRODUCT TAG TORAY INDUSTRIES, INC. (JP) 2022-05-19 US disclosed
US-20090001880-A1 ORGANIC ELECTROLUMINESCENT DEVICE, AN AZEPINE COMPOUND, AND A METHOD FOR MAKING THE SAME FUJIFILM CORPORATION (JP) 2009-01-01 US disclosed
US-20090001880-A1 ORGANIC ELECTROLUMINESCENT DEVICE, AN AZEPINE COMPOUND, AND A METHOD FOR MAKING THE SAME FUJIFILM CORPORATION (JP) 2009-01-01 US disclosed
US-7456567-B2 Organic electroluminescent device, and azepine compound and method for producing the same FUJIFILM CORPORATION (JP) 2008-11-25 US disclosed
US-7456567-B2 Organic electroluminescent device, and azepine compound and method for producing the same FUJIFILM CORPORATION (JP) 2008-11-25 US disclosed
US-20070257256-A1 Photosensing thin film transistor SEIKO EPSON CORPORATION (JP) 2007-11-08 US disclosed
EP-1852923-A2 Photosensing transistors SEIKO EPSON CORPORATION (JP) 2007-11-07 EP disclosed
US-20070232800-A1 Organic electroluminescent device, and azepine compound and method for producing the same FUJI PHOTO FILM CO., LTD. 2007-10-04 US disclosed
US-20070232800-A1 Organic electroluminescent device, and azepine compound and method for producing the same FUJI PHOTO FILM CO., LTD. 2007-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090001880-A1 ORGANIC ELECTROLUMINESCENT DEVICE, AN AZEPINE COMPOUND, AND A METHOD FOR MAKING THE SAME OR10J3, AZI2, LAGE3 ALDH1A1 628/4885TDP1 3738/4885L3MBTL1 510/4885
US-20070232800-A1 Organic electroluminescent device, and azepine compound and method for producing the same OR10J3, AZI2, LAGE3 ALDH1A1 602/4885TDP1 3468/4885L3MBTL1 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.